Tuning the Cytotoxicity of Bis-Phosphino-Amines Ruthenium(II) Para-Cymene Complexes for Clinical Development in Breast Cancer

Despite some limitations such as long-term side effects or the potential presence of intrinsic or acquired resistance, platinum compounds are key therapeutic components for the treatment of several solid tumors. To overcome these limitations, maintaining the same efficacy, organometallic ruthenium(I...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron: Domínguez-Jurado, Elena, Cimas, Francisco J., Castro-Osma, José Antonio, Juan, Alberto, Lara-Sánchez, Agustín, Rodríguez-Diéguez, Antonio, Shafir, Alexandr, Ocaña, Alberto, Alonso-Moreno, Carlos
Fformat: Online Erthygl Texto
Iaith:English
Cyhoeddwyd: MDPI 2021
Pynciau:
Article
Mynediad Ar-lein:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539368/
https://www.ncbi.nlm.nih.gov/pubmed/34683852
http://dx.doi.org/10.3390/pharmaceutics13101559

Rhyngrwyd

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539368/
https://www.ncbi.nlm.nih.gov/pubmed/34683852
http://dx.doi.org/10.3390/pharmaceutics13101559

Eitemau Tebyg